Back
Molecular Partners AG Vs. NLS Pharmaceutics Industry Stock Comparison
Sell
48
MOLN
Molecular Partners AG
Last Price:
3.80
Seasonality Move:
-5.26%
Sell
48
NLSP
NLS Pharmaceutics
Last Price:
0.15
Seasonality Move:
-24.61%
Sell
48
Molecular Partners AG (MOLN)
is a Sell
Is Molecular Partners AG a Buy, Sell or Hold?
- The current Molecular Partners AG [MOLN] share price is $3.78. The Score for MOLN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- MOLN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $0.16. The Score for NLSP is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MOLN Stock Price Chart
What is Molecular Partners AG's stock price today?
-
The Molecular Partners AG share price today is $3.78
The current trend is relatively stagnant and MOLN is experiencing slight buying pressure.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $0.16
The current trend is relatively stagnant and NLSP is experiencing slight selling pressure.
MOLN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 48.95 | Sell |
| Chaikin Money Flow: | 107 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.64 - 3.92) | Sell |
| Bollinger Bands (100): | (3.84 - 4.58) | Sell |
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 56.77 | Buy |
| Chaikin Money Flow: | -52953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.13 - 0.15) | Buy |
| Bollinger Bands (100): | (0.16 - 0.48) | Sell |
MOLN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.75 | Buy |
| 20-day SMA: | 3.79 | Sell |
| 50-day SMA: | 3.9 | Sell |
| 200-day SMA: | 4.46 | Sell |
| 8-day EMA: | 3.76 | Buy |
| 20-day EMA: | 3.79 | Sell |
| 50-day EMA: | 3.92 | Sell |
| 200-day EMA: | 4.61 | Sell |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.15 | Buy |
| 20-day SMA: | 0.14 | Buy |
| 50-day SMA: | 0.18 | Sell |
| 200-day SMA: | 0.51 | Sell |
| 8-day EMA: | 0.15 | Buy |
| 20-day EMA: | 0.15 | Buy |
| 50-day EMA: | 0.19 | Sell |
| 200-day EMA: | 0.48 | Sell |
Molecular Partners AG Earnings Growth & MOLN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.06 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Molecular Partners AG Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NLS Pharmaceutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||